Moderna’s Shares Plummet After Cancer-Vaccine Data Shared on Social Media

The source gives a named company (Moderna), a direction (shares plummet), a catalyst (cancer-vaccine data shared on social media), and a publisher. That is enough to anchor a piece, but the supplied evidence is only a headline. A 150–250 word piece would require inventing facts such as price levels, percentages, trial details, and analyst reactions, which the rules prohibit. The headline gives no number, no quantified move, no trial name, no analyst, and no date.

INSUFFICIENT_SOURCE